Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 11:49 AM
Ignite Modification Date:
2025-12-26 @ 11:49 AM
NCT ID:
NCT01421316
Eligibility Criteria:
Inclusion Criteria:
* Brain metastases
* Age ≥ 18 years.
* Signed informed consent
* Recursive Partitioning Analysis (RPA) class III patients
* Recursive Partitioning Analysis (RPA) class I-II patients and \>3 brain metastases
* Patients with small cell lung cancer extended disease eligible for prophylactic Whole-Brain Radiotherapy (WBRT).
Exclusion Criteria:
* Previous whole brain radiotherapy
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01421316
Study Brief:
Protocol Section:
NCT01421316